External broker reports(aggregated public sources), Taylor Collison

Taylor Collison

External broker reports(aggregated public sources)

Taylor Collison is a leading financial services firm, providing advice & wealth creation strategies to private & institutional investors and corporate clients throughout Australia. Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

<ul><li>NOL continues to win significant marketshare of new business (16.2%) without sacrificing underwriting standards.</li><li>This gives us conviction that NOL will maintain strong earnings growth over the medium term.</li><li>At $1.73, NOL trades at a 34% discount to our 12-month price target of $2.31 (previously $2.14). Our valuation is supported by $1.66ps of backbook. </li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

NOL continues to win significant marketshare of new business (16.2%) without sacrificing underwriting standards.This gives us conviction that NOL will maintain strong earnings growth over the medium term.At $1.73, NOL trades at a 34% discount to our 12-month price target of $2.31 (previously $2.14). Our valuation is supported by $1.66ps of backbook. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Nobleoak Life Limited (NOL) - Strong Growth Ahead

<ul><li>Considering NOL is winning &gt;15% market share of new business in their category, we believe it will grow from its current 2% market share over the medium term.</li><li>This analysis gives us comfort that our forecast gains in market share will not be achieved by taking on more underwriting risk and supports the company’s dialogue that it has disciplined underwriting.</li><li>We maintain our Outperform recommendation and 12-mth price target of $2.14ps.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Considering NOL is winning &gt;15% market share of new business in their category, we believe it will grow from its current 2% market share over the medium term.This analysis gives us comfort that our forecast gains in market share will not be achieved by taking on more underwriting risk and supports the company’s dialogue that it has disciplined underwriting.We maintain our Outperform recommendation and 12-mth price target of $2.14ps.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Nobleoak Life Limited (NOL) - APRA Data Suggests NOL’s Book Is High Quality

<ul><li>NOL trades on an undemanding 13.6x/10.9x our FY23/FY24e EPS.</li><li>Its uncorrelated returns (defensiveness with growth) in an increasing inflationary environment has appeal, with a business model that has a natural hedge to interest rate rises.</li><li>It is well capitalised, the CEO is strongly aligned to shareholder interests and its backbook alone is worth 85% of the market cap based on our calculations.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

NOL trades on an undemanding 13.6x/10.9x our FY23/FY24e EPS.Its uncorrelated returns (defensiveness with growth) in an increasing inflationary environment has appeal, with a business model that has a natural hedge to interest rate rises.It is well capitalised, the CEO is strongly aligned to shareholder interests and its backbook alone is worth 85% of the market cap based on our calculations.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Nobleoak Life Limited (NOL) – Fastest Growing Australian Life Insurer

Australia

NobleOak Life Limited provides life insurance products. The Company offers medical, income protection, total and permanent disability, and business expense insurance products. NobleOak Life serves customers in Australia.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

NobleOak Life (NOL AU)

Nobleoak Life Limited (NOL) - Strong Growth Ahead

At $1.73, NOL trades at a 34% discount to our 12-month price target of $2.31 (previously $2.14). Our valuation is supported by $1.66ps of backbook.

Taylor Collison

Nobleoak Life Limited (NOL) - APRA Data Suggests NOL’s Book Is High Quality

Considering NOL is winning >15% market share of new business in their category, we believe it will grow from its current 2% market share over the...

Taylor Collison

Nobleoak Life Limited (NOL) – Fastest Growing Australian Life Insurer

NOL trades on an undemanding 13.6x/10.9x our FY23/FY24e EPS. Its uncorrelated returns (defensiveness with growth) in an increasing inflationary...

Taylor Collison

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)